Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market ...

The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...

I know I'm no angel and in no position to judge. I'm in recovery for years of substance abuse, after all. But the things I ...

Chicago trial attorney John Drews, like many well-employed Americans, always has given himself a generous discretionary ...

Beloved brands like Ninja, Stanley and Charlotte Tilbury are rolling out new goodies, and we've got the scoop. The pandemic ...

Legend has it that a man visited our newsroom one day years ago insisting that he had come up with the cure for cancer. As the story ...

Researchers said the study backs up anecdotal evidence from patients and doctors that semaglutide can lead to a sudden loss of longing for alcoholic drinks ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

U.S. stock futures were little changed on Thursday night after the major averages slid following a lackluster earnings ...

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

Since GLP-1s hit the mainstream roughly two years ago, people taking the weight-loss drugs noticed ... (Ozempic and Wegovy), ...